Alpha 2.0
Login Register
» Articles » PMID: 21537921

Tolvaptan for Heart Failure Patients with Volume Overload

Overview
Journal Cardiovasc Drugs Ther
Specialties Cardiology & Vascular Diseases
Pharmacology
Date 2011 May 4
PMID 21537921
Citations 4
Authors
Masatsugu Hori
Affiliations
Soon will be listed here.
Citing Articles

QbD green analytical procedure for the quantification of tolvaptan by utilizing stability indicating UHPLC method.

Hashmi S, Alegete P BMC Chem. 2024; 18(1):122.

PMID: 38943221 PMC: 11212186. DOI: 10.1186/s13065-024-01214-2.

Urinary excretion of the water channel aquaporin 2 correlated with the pharmacological effect of tolvaptan in cirrhotic patients with ascites.

Nakanishi H, Kurosaki M, Hosokawa T, Takahashi Y, Itakura J, Suzuki S J Gastroenterol. 2015; 51(6):620-7.

PMID: 26610908 DOI: 10.1007/s00535-015-1143-3.

Can serum albumin level affect the pharmacological action of tolvaptan in patients with liver cirrhosis? A post hoc analysis of previous clinical trials in Japan.

Sakaida I, Nakajima K, Okita K, Hori M, Izumi T, Sakurai M J Gastroenterol. 2015; 50(10):1047-53.

PMID: 25689936 PMC: 4592499. DOI: 10.1007/s00535-015-1052-5.

Triple Diuretics and Aquaretic Strategy for Acute Decompensated Heart Failure due to Volume Overload.

Jermyn R, Rajper N, Estrada C, Patel S, Bloom M, Wadhwa N Case Rep Cardiol. 2014; 2013:750794.

PMID: 24829808 PMC: 4008352. DOI: 10.1155/2013/750794.